795TiP A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors.
Saved in:
| Title: | 795TiP A first-in-human phase I study of LY4170156, an antibody-drug conjugate targeting folate receptor α (FRα)-expressing advanced solid tumors. |
|---|---|
| Authors: | Ray-Coquard, I.L.1 (AUTHOR), Liu, J.F.2 (AUTHOR), O'Malley, D.3 (AUTHOR), Oaknin, A.4 (AUTHOR), Pothuri, B.5 (AUTHOR), Lorusso, D.6 (AUTHOR), Eskander, R.N.7 (AUTHOR), Westin, S.8 (AUTHOR), Lakhani, N.J.9 (AUTHOR), McKean, W.B.10 (AUTHOR), Koyama, T.11 (AUTHOR), Kitano, S.12 (AUTHOR), Lim, M.C.13 (AUTHOR), Gomez-Roca, C.A.14 (AUTHOR), Perez Fidalgo, J.A.15 (AUTHOR), Curigliano, G.16 (AUTHOR), Campone, M.17 (AUTHOR), Sharkey, B.18 (AUTHOR), Avsar, E.18 (AUTHOR), Friedman, C.19 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS593-S594. 2p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.2155 |
